SCHEMBL10148962

SCHEMBL10148962

CC(=O)Oc1cc(C)cc(C(=O)O)c1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TPMT P51580 1/20 0.59
HCAR1 Q9BXC0 1/20 0.52
LMNA P02545 4/20 0.52
HSD17B10 Q99714 1/20 0.50
GAA P10253 2/20 0.46
KDM4E B2RXH2 3/20 0.46
TSHR P16473 2/20 0.46
ALDH1A1 P00352 1/20 0.46
RAB9A P51151 1/20 0.46
ELANE P08246 2/20 0.44
MEN1 O00255 3/20 0.43
KMT2A Q03164 3/20 0.43
POLB P06746 1/20 0.43
CYP4F2 P78329 1/20 0.42
CYP4A11 Q02928 1/20 0.42
BACE1 P56817 1/20 0.42
CNR2 P34972 1/20 0.42
HCAR2 Q8TDS4 1/20 0.41
RXRA P19793 1/20 0.40
RXRB P28702 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30031930 1.00 TPMT (0.59) TPMTHCAR1LMNAHSD17B10GAA
SCHEMBL417129 0.88 HSD17B10 (0.57) TPMTLMNAHSD17B10GAAKDM4E
SCHEMBL1543332 0.88 HSD17B10 (0.57) TPMTLMNAHSD17B10GAAKDM4E
SCHEMBL16957883 0.86 LMNA (0.53) TPMTLMNAHSD17B10GAAKDM4E
SCHEMBL593772 0.83 LMNA (0.63) TPMTLMNAHSD17B10GAAKDM4E
SCHEMBL1701666 0.83 LMNA (0.63) LMNAHSD17B10GAAKDM4ETSHR
SCHEMBL10148964 0.83 LMNA (0.50) TPMTLMNAHSD17B10GAAKDM4E
SCHEMBL969378 0.82 TPMT (0.52) TPMTHCAR1LMNAHSD17B10GAA
SCHEMBL14107665 0.81 MEN1 (0.49) LMNAGAAKDM4EALDH1A1ELANE
SCHEMBL10148956 0.81 LMNA (0.49) TPMTLMNAHSD17B10KDM4ERAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230150951-A1 2,5- OR 2,6-DISUBSTITUTED HYDROQUINONE DERIVATIVES WITH AT LEAST ONE CARBOXY, SULFO OR AMIDO GROUP USEFUL AS MEDICAMENTS OM PHARMA SA (CH) 2023-05-18 US disclosed
CN-115279730-A 2, 5-or 2, 6-disubstituted hydroquinone derivatives having at least one carboxyl, sulfo or amido group useful as medicaments OM药物公司 2022-11-01 CN disclosed
EP-3878837-A1 2,5- OR 2,6-DISUBSTITUTED HYDROQUINONE DERIVATIVES WITH AT LEAST ONE CARBOXY, SULFO OR AMIDO GROUP USEFUL AS MEDICAMENTS OM Pharma SA (CH) 2021-09-15 EP disclosed
US-20160288090-A1 MOLECULARLY IMPRINTED POLYMERS COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) 2016-10-06 US disclosed
US-20120052757-A1 MOLECULARLY IMPRINTED POLYMERS MONASH UNIVERSITY (AU) 2012-03-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230150951-A1 2,5- OR 2,6-DISUBSTITUTED HYDROQUINONE DERIVATIVES WITH AT LEAST ONE CARBOXY, SULFO OR AMIDO GROUP USEFUL AS MEDICAMENTS HRH4, NCOA4, HRH3 TPMT 1781/4885HCAR1 657/4885LMNA 4614/4885
US-20160288090-A1 MOLECULARLY IMPRINTED POLYMERS IPMK, MPI, PIM3 TPMT 1253/4885HCAR1 1630/4885LMNA 3479/4885
US-20120052757-A1 MOLECULARLY IMPRINTED POLYMERS IPMK, MPI, PIM3 TPMT 1253/4885HCAR1 1630/4885LMNA 3479/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.